SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025

23 Apr 2025 17:14:00 By Nasdaq GlobeNewswire

Supernus to Participate in Two Upcoming Investor Conferences

04 Mar 2025 16:30:40 By Nasdaq GlobeNewswire

Supernus to Participate in the TD Cowen 45th Annual Health Care Conference

27 Feb 2025 08:30:00 By Nasdaq GlobeNewswire

Supernus Announces Fourth Quarter and Full Year 2024 Financial Results

25 Feb 2025 16:01:52 By Nasdaq GlobeNewswire

Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression

18 Feb 2025 16:25:37 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Host Conference Call and Webcast on February 25, 2025, to Discuss Fourth Quarter and Full Year 2024 Financial Results

11 Feb 2025 16:30:19 By Nasdaq GlobeNewswire

NetDania - New 12 months High: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

05 Feb 2025 09:45:03 By NetDania Notify

NetDania - New 12 months High: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

04 Feb 2025 12:22:34 By NetDania Notify

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease

04 Feb 2025 09:00:05 By Nasdaq GlobeNewswire

NetDania - New 12 months High: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

30 Jan 2025 09:45:48 By NetDania Notify

NetDania - New 12 months High: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

28 Jan 2025 11:23:40 By NetDania Notify

NetDania - New 12 months High: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

27 Jan 2025 10:40:08 By NetDania Notify

Supernus Announces Label Update for Non-Stimulant ADHD Treatment, Qelbree®, Including New Pharmacodynamic Data and Information for Breastfeeding Women

27 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

Supernus to Participate in the 36th Annual Piper Sandler Healthcare Conference

26 Nov 2024 17:00:18 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference

13 Nov 2024 16:30:46 By Nasdaq GlobeNewswire

NetDania - New 12 months High: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

05 Nov 2024 09:45:03 By NetDania Notify

Supernus Announces Third Quarter 2024 Financial Results

04 Nov 2024 16:05:00 By Nasdaq GlobeNewswire

Supernus Presents Promising Data from Open-Label Phase 2a Study of SPN-820 Data in Major Depressive Disorder at Psych Congress 2024

31 Oct 2024 16:10:46 By Nasdaq GlobeNewswire

NetDania - New 12 months High: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

30 Oct 2024 15:07:03 By NetDania Notify

Supernus Pharmaceuticals to Host Conference Call and Webcast on November 4, 2024 to Discuss Third Quarter 2024 Financial Results

21 Oct 2024 16:25:48 By Nasdaq GlobeNewswire